(RECS) Columbia Trust I - - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US19761L7064 • Large Blend
RECS: Stocks, Bonds, US, Large-cap, Mid-cap, Growth, Value
The Columbia Research Enhanced Core ETF (RECS) is designed to track the performance of a rules-based index that selects a subset of companies from the Russell 1000® Index. The fund invests at least 80% of its assets in the securities of this index, which focuses on U.S. large- and mid-cap companies. By applying a systematic methodology, the index aims to balance growth and value exposures, typically holding between 325 to 400 companies. This range can vary as the index does not impose a fixed limit on the number of holdings.
RECS is structured as a large blend ETF, meaning it combines both growth and value stocks within the large-cap space. The fund’s market capitalization is approximately $1.895 billion, and it is listed on the NYSE ARCA under the ticker symbol RECS. While the fund does not explicitly target a specific P/E, P/B, or P/S ratio, its rules-based approach ensures diversification across sectors and companies. The expense ratio is designed to be competitive within its category, making it accessible for investors seeking broad exposure to U.S. equities with a systematic twist.
For investors and fund managers, RECS offers a transparent and cost-effective way to gain exposure to a diversified portfolio of U.S. large- and mid-cap companies. The fund’s rules-based methodology eliminates emotional decision-making, ensuring consistency in its investment approach. This makes it a potential core holding for portfolios seeking balanced exposure to growth and value styles within the large-cap universe.
Additional Sources for RECS ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
RECS ETF Overview
Market Cap in USD | 2,115m |
Category | Large Blend |
TER | 0.15% |
IPO / Inception | 2019-09-25 |
RECS ETF Ratings
Growth 5y | 91.5% |
Fundamental | - |
Dividend | 41.0% |
Rel. Strength Industry | 0.17 |
Analysts | - |
Fair Price Momentum | 35.32 USD |
Fair Price DCF | - |
RECS Dividends
Dividend Yield 12m | 1.14% |
Yield on Cost 5y | 3.00% |
Annual Growth 5y | 7.12% |
Payout Consistency | 70.5% |
RECS Growth Ratios
Growth Correlation 3m | -20.7% |
Growth Correlation 12m | 90.6% |
Growth Correlation 5y | 88% |
CAGR 5y | 21.64% |
CAGR/Max DD 5y | 0.98 |
Sharpe Ratio 12m | 1.84 |
Alpha | 0.49 |
Beta | 0.94 |
Volatility | 24.65% |
Current Volume | 359.6k |
Average Volume 20d | 504.2k |
As of March 18, 2025, the stock is trading at USD 33.50 with a total of 359,600 shares traded.
Over the past week, the price has changed by +0.63%, over one month by -7.15%, over three months by -5.64% and over the past year by +11.85%.
Yes. Based on ValueRay Analyses, Columbia Trust I - (NYSE ARCA:RECS) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 91.51 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RECS as of March 2025 is 35.32. This means that RECS is currently overvalued and has a potential downside of 5.43%.
Columbia Trust I - has no consensus analysts rating.
According to ValueRays Forecast Model, RECS Columbia Trust I - will be worth about 40.6 in March 2026. The stock is currently trading at 33.50. This means that the stock has a potential upside of +21.28%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 40.6 | 21.3% |